Who
Jeremy R. Graff
Officer
Company insider
Files Form 4 as: Cdo, Allarity Therapeutics; Director, IN8bio.
In numbers
- Trades disclosed
- 28
- Buys
- 1
- Sells
- 0
- Bought
- $2,375
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 1 May 2023
- Last trade
- 30 Sep 2026
- Last filed
- 9 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 9 Oct 2026 | ALLR Allarity TherapeuticsBiotechnology | SEC FORM 4 Code M | —39,494 | filing |
| 30 Sep 2026filed 9 Oct 2026 | ALLR Allarity TherapeuticsBiotechnology | SEC FORM 4 Code F | $14K14,613 at $0.97 | filing |
| 30 Sep 2026filed 9 Oct 2026 | ALLR Allarity Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —39,494 at $0.00 | filing |
| 9 May 2026filed 12 May 2026 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 9 May 2026filed 12 May 2026 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 28 Jan 2026filed 30 Apr 2026 | ALLR Allarity TherapeuticsBiotechnology | SEC FORM 4 Code A | —133,333 at $0.00 | filing |
| 28 Jan 2026filed 30 Apr 2026 | ALLR Allarity TherapeuticsBiotechnology | SEC FORM 4 Code A | —133,333 at $0.00 | filing |
| 22 Jan 2026filed 9 Oct 2026 | ALLR Allarity TherapeuticsBiotechnology | SEC FORM 4 Code M | —48,147 | filing |
| 22 Jan 2026filed 9 Oct 2026 | ALLR Allarity TherapeuticsBiotechnology | SEC FORM 4 Code F | $21K17,814 at $1.18 | filing |
| 22 Jan 2026filed 9 Oct 2026 | ALLR Allarity Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —48,147 at $0.00 | filing |
| 7 Jan 2026filed 16 Jan 2026 | ALLR Allarity TherapeuticsBiotechnology | SEC FORM 4 Code A | —133,333 at $0.00 | filing |
| 7 Jan 2026filed 16 Jan 2026 | ALLR Allarity TherapeuticsBiotechnology | SEC FORM 4 Code A | —133,333 at $0.00 | filing |
| 30 Sep 2025filed 2 Oct 2025 | ALLR Allarity Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —39,494 at $0.00 | filing |
| 30 Sep 2025filed 2 Oct 2025 | ALLR Allarity TherapeuticsBiotechnology | SEC FORM 4 Code M | —39,494 | filing |
| 30 Sep 2025filed 2 Oct 2025 | ALLR Allarity TherapeuticsBiotechnology | SEC FORM 4 Code F | $23K14,613 at $1.58 | filing |
| 8 May 2025filed 12 May 2025 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —63,150 at $0.00 | filing |
| 27 Apr 2025filed 7 May 2025 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code D | —2,049 | filing |
| 27 Apr 2025filed 7 May 2025 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —2,049 | filing |
| 22 Jan 2025filed 24 Jan 2025 | ALLR Allarity TherapeuticsBiotechnology | SEC FORM 4 Code A | —144,441 at $0.00 | filing |
| 19 Dec 2024filed 23 Dec 2024 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —47,697 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.